CORONAVIRUS: Pfizer study shows that third dose of coronavirus vaccine is associated with a five-fold increase in antibodies in those aged 18-55 and an eleven-fold increase in those aged 65-85.

CORONAVIRUS: Pfizer study shows that third dose of coronavirus vaccine is associated with a five-fold increase in antibodies in those aged 18-55 and an eleven-fold increase in those aged 65-85.

CORONAVIRUS: Pfizer study shows that third dose of coronavirus vaccine is associated with a five-fold increase in antibodies in those aged 18-55 and an eleven-fold increase in those aged 65-85.
— The Spectator Index (@spectatorindex) 2021-07-29 05:41